Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin

American Heart Journal

Volumn 158, Issue 2, 2009, Pages 252-256

  Tischenko, Alex ^a   Gula, Lorne J ^a   Yee, Raymond ^a   Klein, George J ^a   Skanes, Allan C ^a   Krahn, Andrew D ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; AXILLARY ARTERY; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HEMATOMA; HOSPITAL DISCHARGE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SUBCLAVIAN ARTERY; THROMBOEMBOLISM; VEIN PUNCTURE; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DALTEPARIN; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FIBRINOLYTIC AGENTS; HEMATOMA; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM; WARFARIN;

EID: 67650541562     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.06.005     Document Type: Article

References (20)

1. Wiegand U.K., LeJeune D., Boguschewski F., et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 126 (2004) 1177-1186
2. Giudici M.C., Paul D.L., Bontu P., et al. Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy. Pacing Clin Electrophysiol 27 (2004) 358-360
3. Douketis J.D., Berger P.B., Dunn A.S., et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133 6 Suppl (2008) 299S-339S
4. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8 (2006) 651-745
5. Torn M., and Rosendaal F.R. Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol 123 (2003) 676-682
6. Garcia D.A., Regan S., Henault L.E., et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 168 (2008) 63-69
7. Kearon C., and Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 336 (1997) 1506-1511
8. Dunn A.S., and Turpie A.G. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 163 (2003) 901-908
9. Blacker D.J., Wijdicks E.F., and McClelland R.L. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 61 (2003) 964-968
10. Spyropoulos A.C., Bauersachs R.M., Omran H., et al. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin 22 (2006) 1109-1122
11. Kovacs M.J., Kearon C., Rodger M., et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 110 (2004) 1658-1663
12. Marquie C., De Geeter G., Klug D., et al. Post-operative use of heparin increases morbidity of pacemaker implantation. Europace 8 (2006) 283-287
13. Michaud G.F., Pelosi Jr. F., Noble M.D., et al. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol 35 (2000) 1915-1918
14. Carrel T.P., Klingenmann W., Mohacsi P.J., et al. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review. J Heart Valve Dis 8 (1999) 392-398
15. al-Khadra A.S. Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients. Pacing Clin Electrophysiol 26 1 Pt 2 (2003) 511-514
16. Goldstein D.J., Losquadro W., and Spotnitz H.M. Outpatient pacemaker procedures in orally anticoagulated patients. Pacing Clin Electrophysiol 21 (1998) 1730-1734
17. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
18. Jamula E., Douketis J.D., and Schulman S. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. J Thromb Haemost 6 (2008) 1615-1621
19. Douketis J.D., Crowther M.A., Cherian S.S., et al. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 116 (1999) 1240-1246
20. Birnie D., Healey J.S., Krahn A., et al. Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design. Curr Opin Cardiol 24 (2009) 82-87